Skip to content

Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis

The Use Tradition Chinese Native Medicine Treats the Osteoporosis Research

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00154609
Enrollment
100
Registered
2005-09-12
Start date
2002-01-31
Completion date
Unknown
Last updated
2006-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

We, the investigators at National Taiwan University Hospital, have determined the therapeutic and toxic effects of the traditional herb on the ovariectomized Wistar rat. The final years will determine its effects on the therapy of women who are over 45 years old and postmenopausal with osteoporosis.

Detailed description

Research of this traditional chinese clinical medicine, Gusuibu, curative effect is planned for three years time. The entire study aims to evaluate the effect of the traditional chinese medicine on postmenopausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal women with established osteoporosis.

Interventions

DRUGGu-Sui-Bu (Davallia Divaricata)

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Postmenopausal osteoporosis

Exclusion criteria

* Insulin dependent diabetes

Design outcomes

Primary

MeasureTime frame
The project is aimed to investigate the clinical effects of the water extract of Gu-Sui-Bu from the aspects of animal and clinic studies.

Countries

Taiwan

Contacts

Primary ContactLiu Hwa-Chang, Ph.D
hcliu@ha.mc.ntu.edu.tw886-2-23956988

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026